Does Lactobacillus GG prevent antibiotic-associated diarrhea in children? Part A: Evidence-based answer and summary

Paediatrics and Child Health

Volumn 10, Issue 3, 2005, Pages

  Johnston, Bradley C ^a   Cramer, Kristie ^a   Vohra, Sunita ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPENICILLIN; ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; PROBIOTIC AGENT;

ABDOMINAL ABSCESS; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL STRAIN; CLINICAL TRIAL; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; ENDOCARDITIS; EVIDENCE BASED MEDICINE; FINLAND; HUMAN; INTESTINE FLORA; LACTOBACILLUS; META ANALYSIS; NOTE; PNEUMONIA; SEPTICEMIA; SYSTEMATIC REVIEW;

EID: 17644383764     PISSN: 12057088     EISSN: None     Source Type: Journal    
DOI: 10.1093/pch/10.3.169     Document Type: Note

References (17)

1. Havenaar R, Huis In't Veld JHS. Probiotics: A general view. In: Wood BJB, ed. The Lactic Acid Bacteria in Health and Disease. Amsterdam: Elsevier, 1992:1-200.
2. Gismondo MR. Review of probiotics available to modify gastrointestinal flora. Int J Antimicrob Agents 1999;12:287-92.
3. Goldin BR. Health benefits of probiotics. Br J Nutr 1998;80:S203-7.
4. Wistrom J, Norrby SR, Myhre EB, et al. Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: A prospective study. J Antimicrobial Chemother 2001;47:43-50.
5. McFarland LV. Epidemiology, risk factors and treatments for antibiotic-associated diarrhea. Dig Dis 1998;16:292-307.
6. Elstner CL, Lindsay AN, Book LS, Matsen JM. Lack of relationship of Clostridium difficile to antibiotic-associated diarrhea in children. Pediatr Infect Dis 1983;2:364-6.
7. D'Souza AL, Rakkumar C, Cooke J, Bulpitt CJ. Probiotics in prevention of antibiotic-associated diarrhea: Meta-analysis. BMJ 2002;324:1361-4.
8. Cremonini F, Di Caro S, Nista EC, et al. Meta-analysis: The effect of probiotic administration on antibiotic associated diarrhea. Aliment Pharmacol Ther 2002;16:1461-7.
9. Salminen S, Wright AV, Morelli L, et al. Demonstration of safety of probiotics - a review. Int J Food Microbiol 1998;44:93-106.
10. Salminen MK, Rautelin H, Tynkkynen S, et al. Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG. Clin Infect Dis 2004;38:62-9.
11. Saxelin M, Chuang NH, Chassy B, et al. Lactobacilli and Bacteremia in Southern Finland, 1989-1992. Clin Infect Dis 1996;22:564-6.
12. Land MH, Rouster-Stevens K, Woods CR, Cannon ML, Cnota J, Shetty AK. Lactobacillus sepsis associated with probiotic therapy. Pediatrics 2005;115:178-81.
13. Rautio M, Jousimies-Somer H, Kauma H, et al. Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG. Clin Infect Dis 1999;28:1159-60.
14. Mackay AD, Taylor MB, Kibbler CC, Hamilton-Miller JM. Lactobacillus endocarditis caused by a probiotic organism. Clin Microbiol Infect 1999;5:290-2.
15. Vanderhoof JA, Whitney DB, Antonson DL, et al. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatr 1999;135:564-8.
16. Arvola T, Laiho K, Torkkeli S, et al. Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: A randomized study. Pediatrics 1999;104:e64.
17. Jadad AR, Moore RA, Carrol D, et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 1996;17:1-12.